ESR1 and breast carcinoma: Our analysis of breast cancer cell lines, however, was not able to replicate the previously reported correlation of APOBEC3B expression level in vivo with resistance to tamoxifen in a clinical setting or in murine xenograft models in ER+ breast cancer [18] due to the lack of statistical significance.